These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 25742223)
21. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. Myers LL; Wax MK J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320 [TBL] [Abstract][Full Text] [Related]
23. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings. Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574 [TBL] [Abstract][Full Text] [Related]
24. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
25. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716 [TBL] [Abstract][Full Text] [Related]
27. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers]. Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658 [TBL] [Abstract][Full Text] [Related]
28. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746 [TBL] [Abstract][Full Text] [Related]
29. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation. Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma. Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326 [No Abstract] [Full Text] [Related]
32. 18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement. Krabbe CA; Pruim J; Scholtens AM; Roodenburg JL; Brouwers AH; Phan TT; Agool A; Dijkstra PU J Oral Maxillofac Surg; 2010 Jan; 68(1):21-7. PubMed ID: 20006150 [TBL] [Abstract][Full Text] [Related]
33. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789 [TBL] [Abstract][Full Text] [Related]
34. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma. Huang SH; Chien CY; Lin WC; Fang FM; Wang PW; Lui CC; Huang YC; Hung BT; Tu MC; Chang CC Clin Nucl Med; 2011 Jul; 36(7):518-25. PubMed ID: 21637051 [TBL] [Abstract][Full Text] [Related]
35. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. Dammann F; Horger M; Mueller-Berg M; Schlemmer H; Claussen CD; Hoffman J; Eschmann S; Bares R AJR Am J Roentgenol; 2005 Apr; 184(4):1326-31. PubMed ID: 15788619 [TBL] [Abstract][Full Text] [Related]
36. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT. Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570 [TBL] [Abstract][Full Text] [Related]
37. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
38. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology. Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350 [TBL] [Abstract][Full Text] [Related]
39. Positron-emission tomography pitfalls related to oral prosthesis. More Y; Dusing R; Counts S; Bond J; Tsue T; Girod D Laryngoscope; 2013 Feb; 123(2):404-6. PubMed ID: 22778055 [TBL] [Abstract][Full Text] [Related]
40. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective. Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]